A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

Trial Profile

A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors TTY Biopharm
  • Most Recent Events

    • 11 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 08 May 2014 Planned end date changed from 1 Dec 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
    • 18 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top